Science Explorer Back to mapMap
Discussion
Company · La Jolla · United States

Behavioral Pharma (United States)

In research, Behavioral Pharma (United States) stands highest in Health Sciences (#3,262 of 9,902 worldwide), 2022-now. Relative to its size it is most specialised in Neuroscience (Neuroscience is 10.6× its share of world research).

behavioralpharma.comROR OpenAlex
World rank, 2022-now
#8,258
of 22,385 · #3,688 all time
Rank in United States
#1,112
of 3,332
Research works
1.3k
▲ 24% vs 2018-21
Citations
72k
54.4 per fractional work
Top-10% rate
16.5%
all institutions 10.0%
vs its own fields
1.12×
1.00× is exactly expected
Open access
35%
world 40%
International
15%
world 18%
Behavioral Pharma (United States)

What is Behavioral Pharma (United States) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #3,262 of 9,902 17.5%64 #1933

Each strip is that field's whole ranked pool, with the notch where Behavioral Pharma (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Behavioral Pharma (United States) work in?

In 2022-now, 38% of research at Behavioral Pharma (United States) is in Health Sciences, 29% in Social Sciences. Its largest fields are Medicine (34%), Psychology (23%), Neuroscience (17%). It does 2.0× the world's share of Life Sciences.

Health Sciences: 76 fractional works · 38.3% of its workMedicine: 68 fractional works · 34.2% of its workEpidemiology: 10 fractional works · 5.1% of its workPharmacology: 10 fractional works · 5.1% of its workPublic Health, Environmental and Occupational Health: 9 fractional works · 4.7% of its workPsychiatry and Mental health: 8 fractional works · 4.0% of its workPhysiology: 7 fractional works · 3.3% of its workNeurology: 5 fractional works · 2.3% of its workPediatrics, Perinatology and Child Health: 4 fractional works · 2.1% of its workPathology and Forensic Medicine: 2 fractional works · 0.8% of its workAnesthesiology and Pain Medicine: 2 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 0.6% of its workSurgery: 1 fractional works · 0.5% of its workEmergency Medicine: 1 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.4% of its workOncology: 1 fractional works · 0.3% of its workComplementary and alternative medicine: 1 fractional works · 0.3% of its workRheumatology: 1 fractional works · 0.3% of its workGenetics: 1 fractional works · 0.3% of its workInfectious Diseases: 1 fractional works · 0.3% of its workGeriatrics and Gerontology: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 1.2% of its workHealth Professions: 6 fractional works · 2.8% of its workGeneral Health Professions: 4 fractional works · 1.9% of its workPharmacy: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.6% of its workNursing: 1 fractional works · 0.7% of its workNutrition and Dietetics: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 1 fractional works · 0.4% of its workSmall Animals: 1 fractional works · 0.4% of its workDentistry: 0 fractional works · 0.2% of its workSocial Sciences: 57 fractional works · 28.9% of its workPsychology: 45 fractional works · 22.5% of its workClinical Psychology: 21 fractional works · 10.5% of its workExperimental and Cognitive Psychology: 11 fractional works · 5.6% of its workSocial Psychology: 6 fractional works · 2.8% of its workDevelopmental and Educational Psychology: 4 fractional works · 2.2% of its workApplied Psychology: 2 fractional works · 1.1% of its workGeneral Psychology: 0 fractional works · 0.2% of its workSocial Sciences: 10 fractional works · 4.8% of its workSociology and Political Science: 3 fractional works · 1.4% of its workEducation: 2 fractional works · 0.9% of its workPolitical Science and International Relations: 1 fractional works · 0.6% of its workHealth: 1 fractional works · 0.5% of its workGender Studies: 1 fractional works · 0.4% of its workCultural Studies: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.7% of its workDecision Sciences: 1 fractional works · 0.6% of its workGeneral Decision Sciences: 1 fractional works · 0.3% of its workInformation Systems and Management: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 1 fractional works · 0.5% of its workMarketing: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workEconomics and Econometrics: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.2% of its workLife Sciences: 55 fractional works · 27.7% of its workNeuroscience: 34 fractional works · 17.2% of its workCognitive Neuroscience: 15 fractional works · 7.4% of its workCellular and Molecular Neuroscience: 9 fractional works · 4.7% of its workNeurology: 3 fractional works · 1.6% of its workEndocrine and Autonomic Systems: 2 fractional works · 1.2% of its workBiological Psychiatry: 2 fractional works · 1.0% of its workBehavioral Neuroscience: 1 fractional works · 0.6% of its workSensory Systems: 1 fractional works · 0.4% of its workDevelopmental Neuroscience: 1 fractional works · 0.3% of its workBiochemistry, Genetics and Molecular Biology: 11 fractional works · 5.6% of its workMolecular Biology: 6 fractional works · 3.2% of its workGenetics: 3 fractional works · 1.4% of its workBiochemistry: 0 fractional works · 0.3% of its workCancer Research: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 7 fractional works · 3.4% of its workToxicology: 5 fractional works · 2.6% of its workPharmacology: 1 fractional works · 0.5% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workImmunology and Microbiology: 2 fractional works · 0.9% of its workImmunology: 1 fractional works · 0.5% of its workVirology: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 0.6% of its workPlant Science: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 10 fractional works · 5.1% of its workComputer Science: 4 fractional works · 1.9% of its workArtificial Intelligence: 2 fractional works · 1.0% of its workComputer Vision and Pattern Recognition: 1 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.2% of its workHuman-Computer Interaction: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 2 fractional works · 1.0% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 0.6% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 2 fractional works · 0.9% of its workOrganic Chemistry: 2 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMathematics: 1 fractional works · 0.6% of its workStatistics and Probability: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 1 fractional works · 0.3% of its workBiomedical Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workALL ITS WORKBehavioral Pharma(United States)199fractional works, 2022-now
Life Sciences28%Physical Sciences5%Health Sciences38%Social Sciences29%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Medicine6834.2%
    2. Health Professions62.8%
    3. Nursing10.7%
    4. Veterinary10.4%
    5. Dentistry00.2%
    1. Psychology4522.5%
    2. Social Sciences104.8%
    3. Decision Sciences10.6%
    4. Business, Management and Accounting10.5%
    5. Economics, Econometrics and Finance00.2%
    6. Arts and Humanities00.2%
    1. Neuroscience3417.2%
    2. Biochemistry, Genetics and Molecular Biology115.6%
    3. Pharmacology, Toxicology and Pharmaceutics73.4%
    4. Immunology and Microbiology20.9%
    5. Agricultural and Biological Sciences10.6%
    1. Computer Science41.9%
    2. Environmental Science21.0%
    3. Chemistry20.9%
    4. Mathematics10.6%
    5. Materials Science10.4%
    6. Engineering10.3%
    7. Physics and Astronomy00.1%
    8. Chemical Engineering00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Behavioral Pharma (United States) specialise in?

Where its research is concentrated relative to its size: Neuroscience takes 10.6× the share of its output that it takes of world research.

  1. NeuroscienceField · 34.3 works11×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.13× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.04× its world share, 11 worksBiochemistry, Geneti…Immunology and Microbiology: 0.86× its world share, 2 worksImmunology and Micro…Neuroscience: 10.63× its world share, 34 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.59× its world share, 7 worksPharmacology, Toxico…Chemical Engineering: 0.06× its world share, 0 worksChemical EngineeringChemistry: 0.59× its world share, 2 worksChemistryComputer Science: 0.24× its world share, 4 worksComputer ScienceEngineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.21× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.10× its world share, 1 worksMaterials ScienceMathematics: 0.47× its world share, 1 worksMathematicsPhysics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyDentistry: 0.43× its world share, 0 worksDentistryHealth Professions: 1.08× its world share, 6 worksHealth ProfessionsMedicine: 1.78× its world share, 68 worksMedicineNursing: 1.37× its world share, 1 worksNursingVeterinary: 2.90× its world share, 1 worksVeterinaryArts and Humanities: 0.07× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.14× its world share, 1 worksBusiness, Management…Decision Sciences: 0.67× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.11× its world share, 0 worksEconomics, Econometr…Psychology: 7.39× its world share, 45 worksPsychologySocial Sciences: 0.38× its world share, 10 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 10.6×. Every wedge is a field page.

All 24 fields, with their numbers
  1. Neuroscience10.63×34 works
  2. Pharmacology, Toxicology and Pharmaceutics9.59×7 works
  3. Psychology7.39×45 works
  4. Veterinary2.90×1 works
  5. Medicine1.78×68 works
  6. Nursing1.37×1 works
  7. Health Professions1.08×6 works
  8. Biochemistry, Genetics and Molecular Biology1.04×11 works
  9. Immunology and Microbiology0.86×2 works
  10. Decision Sciences0.67×1 works
  11. Chemistry0.59×2 works
  12. Mathematics0.47×1 works
  13. Dentistry0.43×0 works
  14. Social Sciences0.38×10 works
  15. Computer Science0.24×4 works
  16. Environmental Science0.21×2 works
  17. Business, Management and Accounting0.14×1 works
  18. Agricultural and Biological Sciences0.13×1 works
  19. Economics, Econometrics and Finance0.11×0 works
  20. Materials Science0.10×1 works
  21. Arts and Humanities0.07×0 works
  22. Chemical Engineering0.06×0 works
  23. Physics and Astronomy0.03×0 works
  24. Engineering0.02×0 works

Who are the top researchers at Behavioral Pharma (United States)?

Ranked on the quality score, Lisa Medalie, Marc R. Azar and R. H. Bennett lead among researchers whose main affiliation is Behavioral Pharma (United States).

  1. 1 Lisa Medalie United States · #2,014,463 worldwide 206 citations · 22 works
  2. 2 Marc R. Azar United States · #2,458,698 worldwide 980 citations · 35 works
  3. 3 R. H. Bennett United States · #4,638,686 worldwide 311 citations · 25 works
All ranked researchers at Behavioral Pharma (United States)

What are the most cited papers from Behavioral Pharma (United States)?

The most cited paper from Behavioral Pharma (United States) is "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance" (Roland R. Griffiths, William A. Richards, U. McCann et al., 2006), with 1,716 citations. Next come "The Association of Sleep and Pain: An Update and a Path Forward" (1,622) and "Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers" (1,468).

Most cited papers
#PaperReleasedCitations
1 Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Roland R. Griffiths, William A. Richards, U. McCann et al. · Psychopharmacology 7 Jul 2006 1,716
2 The Association of Sleep and Pain: An Update and a Path Forward Patrick H. Finan, Burel R. Goodin, Michael T. Smith · Journal of Pain Open access 27 Nov 2013 1,622
3 Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers Warren Kurt Bickel, Amy L. Odum, Gregory J. Madden · Psychopharmacology 21 Oct 1999 1,468
4 Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety John T. Walkup, Anne Marie Albano, John C. Piacentini et al. · New England Journal of Medicine Open access 30 Oct 2008 1,455
5 Pain catastrophizing: a critical review Phillip J. Quartana, Claudia M. Campbell, Robert Randolph Edwards · Expert Review of Neurotherapeutics Open access 29 Apr 2009 1,409
All 60 most cited papers, with filters and sorting

Which keywords describe research at Behavioral Pharma (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Depression, Epidemiology, Neurological Disorders, Anxiety, Neurobiology, Serotonin, Substance Use Disorders and Psychiatric Disorders.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology23▲ 2.9×44 topics
  2. Depression20▲ 11×20 topics
  3. Neurological Disorders13▲ 12×16 topics
  4. Anxiety13▲ 13×12 topics
  5. Neurobiology13▲ 24×9 topics
  6. Serotonin12▲ 143×2 topics
  7. Treatment11▲ 4.7×10 topics
  8. Substance Use Disorders10▲ 69×2 topics
  9. Psychiatric Disorders9▲ 34×4 topics
  10. Meta-Analysis9▲ 7.7×9 topics
  11. Behavioral Interventions9▲ 53×2 topics
  12. Genetics8▲ 6.0×10 topics
  13. Stress8▲ 11×7 topics
  14. Circadian Rhythms8▲ 37×2 topics
  15. Prevalence8▲ 9.7×10 topics
  16. Health Consequences8▲ 14×3 topics
  17. Neuroprotection8▲ 11×5 topics
  18. Prefrontal Cortex7▲ 43×3 topics
  19. Metabolic Disorders7▲ 30×3 topics
  20. Cannabinoid Receptors7▲ 105×1 topic
  21. Endocannabinoid System7▲ 105×1 topic
  22. Neural Plasticity7▲ 19×5 topics
  23. Impulsivity7▲ 62×2 topics
  24. Adolescents7▲ 9.1×7 topics
  25. Global Burden of Disease6▲ 13×4 topics
  26. Cognitive Behavioral Therapy6▲ 22×2 topics
  27. Mortality Risk6▲ 13×5 topics
  28. Psilocybin6▲ 193×1 topic
  29. Psychedelics6▲ 193×1 topic
  30. Therapeutic6▲ 34×2 topics
  31. Alcohol Dependence6▲ 75×1 topic
  32. Motivational Interviewing6▲ 75×1 topic
  33. Genetic Variation6▲ 14×4 topics
  34. Psychometric Evaluation6▲ 30×2 topics
  35. Neuroimaging6▲ 10×11 topics
  36. Dopamine5▲ 110×1 topic
  37. Insomnia5▲ 37×2 topics
  38. Reward Circuitry5▲ 110×1 topic
  39. Emotion Regulation5▲ 8.4×7 topics
  40. Drug Analysis5▲ 134×1 topic

Which research topics does Behavioral Pharma (United States) publish most on?

By volume in 2022-now: Cannabis and Cannabinoid Research, Psychedelics and Drug Studies, Substance Abuse Treatment and Outcomes and Neurotransmitter Receptor Influence on Behavior.

Cannabis and Cannabinoid…7Cannabis and Cannabinoid Research: 7 fractional worksPsychedelics and Drug St…6Psychedelics and Drug Studies: 6 fractional worksSubstance Abuse Treatmen…6Substance Abuse Treatment and Outcomes: 6 fractional worksNeurotransmitter Recepto…5Neurotransmitter Receptor Influence on Behavior: 5 fractional worksSleep and related disorders: 5 fractional worksForensic Toxicology and Drug Analysis: 5 fractional worksOpioid Use Disorder Trea…4Opioid Use Disorder Treatment: 4 fractional worksSleep and Wakefulness Research: 3 fractional worksSmoking Behavior and Cessation: 3 fractional worksBehavioral and Psychological Studies: 2 fractional works
PharmacologyClinical PsychologyEpidemiologyCellular and Molecular Neuroscience6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cannabis and Cannabinoid Research Pharmacology 7 works
  2. 2 Psychedelics and Drug Studies Clinical Psychology 6 works
  3. 3 Substance Abuse Treatment and Outcomes Epidemiology 6 works
  4. 4 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 5 works
  5. 5 Sleep and related disorders Experimental and Cognitive Psychology 5 works
  6. 6 Forensic Toxicology and Drug Analysis Toxicology 5 works
  7. 7 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 4 works
  8. 8 Sleep and Wakefulness Research Cognitive Neuroscience 3 works
  9. 9 Smoking Behavior and Cessation Physiology 3 works
  10. 10 Behavioral and Psychological Studies Developmental and Educational Psychology 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.9%not open65.1%

World: 40% of research is openly available.

with international co-authors14.7%domestic only85.3%

World: 18% is written across borders.

How has Behavioral Pharma (United States)'s research output changed?

Output in 2022-2025 was 24% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Behavioral Pharma (United States) as a percentage of every work published that year, 0.00066% in 2024.

still counting0.0020%0.0040%0.0060%Behavioral Pharma (United States)0.00088% in 202519801990200020102020

Fractional works of Behavioral Pharma (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%30%Behavioral Pharma (United States)13.5% in 2025all institutions10.0% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 22.7% in 2020.

Other research institutions in La Jolla

All research institutions in La Jolla

Share Behavioral Pharma (United States)'s ranking

Behavioral Pharma (United States) on Science Explorer

A card with Behavioral Pharma (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Behavioral Pharma (United States). Posts are plain text and can be reported.